Published in Ann Surg on June 01, 1996
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
Liver resection for colorectal metastases: the third hepatectomy. Ann Surg (2003) 2.57
Indicators for treatment strategies of colorectal liver metastases. Ann Surg (2000) 1.26
Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford) (2011) 0.93
Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) (2010) 0.90
Initial experiences of simultaneous laparoscopic resection of colorectal cancer and liver metastases. HPB Surg (2012) 0.87
Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer. Int J Colorectal Dis (2005) 0.83
Aggressive treatment of patients with metastatic colorectal cancer increases survival: a scandinavian single-center experience. HPB Surg (2013) 0.79
Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection. Ann Surg Oncol (2015) 0.79
Recurrence after hepatic resection in colorectal cancer liver metastasis -Review article-. J Med Life (2015) 0.79
Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg (2011) 0.77
Safety analysis of the oncological outcome after vein-preserving surgery for colorectal liver metastases detached from the main hepatic veins. Langenbecks Arch Surg (2015) 0.77
High survival in patients operated for small isolated liver metastases from gastric cancer: a multi-institutional study. World J Surg (2014) 0.76
Hepatectomy for colorectal hepatic metastases. World J Surg (2000) 0.75
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg (1990) 4.36
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery (1988) 3.47
Cancer statistics, 1993. CA Cancer J Clin (1993) 3.43
Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery (1991) 3.35
The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg (1984) 3.08
Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg (1989) 2.79
Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg (1987) 2.58
A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol (1991) 2.46
Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet (1986) 2.21
Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol (1994) 1.77
Repeat hepatic resections for colorectal metastases. Surgery (1990) 1.45
Recurrence of colorectal cancer after hepatic resection. Am J Surg (1988) 1.39
Repeat hepatectomy for recurrent malignant tumors of the liver. Surg Gynecol Obstet (1989) 1.23
Results of extensive surgery for liver metastases in colorectal carcinoma. Br J Surg (1992) 1.21
Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery (1995) 1.21
Repeat liver resection for recurrent colorectal metastases. Br J Surg (1993) 1.20
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg (1996) 1.19
Resection of synchronous liver metastases from colorectal cancer. World J Surg (1991) 1.15
Patterns of failure after surgical cure of large liver tumors. A change in the proximate cause of death and a need for effective systemic adjuvant therapy. Am J Surg (1984) 1.14
Repeat hepatic resection for primary and metastatic carcinoma of the liver. Surg Gynecol Obstet (1990) 1.09
Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol (1990) 1.08
Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg (1990) 1.06
Repeat hepatic resections for metastatic colorectal cancer. Ann Surg (1994) 1.05
Resection of liver metastases from colorectal cancer. Indications and results. Dis Colon Rectum (1994) 1.05
A ten year experience with hepatic resection. Surg Gynecol Obstet (1984) 1.02
Repeated hepatic resection for recurrent metastases from colorectal cancer. Br J Surg (1992) 0.96
Repeat hepatectomy for cancer. Br J Surg (1993) 0.94
Complications of hepatic resection for colorectal carcinoma metastasis. Am Surg (1992) 0.90
Regional treatment of hepatic metastases and hepatocellular carcinoma. Curr Probl Cancer (1989) 0.84
Resection of 'recurrent' colorectal metastases to the liver. Br J Surg (1994) 0.83
Repeated hepatic resection. Int Surg (1987) 0.83
Aggressive repeat liver resection for hepatic metastases of colorectal carcinoma. Surg Today (1992) 0.82
Second hepatic resection for metastatic colorectal cancer. Eur J Surg Oncol (1991) 0.81
Colorectal metastases to the liver: present results and future strategies. J Surg Oncol Suppl (1991) 0.80
Surgical management of recurrent liver tumors. Semin Oncol (1993) 0.79
Redo hepatic resection for metastatic colorectal carcinoma. World J Surg (1994) 0.79
Repeat resection of recurrent hepatic colorectal metastases. Br J Surg (1994) 0.78
Repeated hepatic resections for liver metastases from colon carcinoma. Montpellier Cancer Institute experience. Eur J Surg Oncol (1994) 0.77
Optimal exposure for hepatobiliary operations using the Bookwalter self-retaining retractor. Am Surg (1995) 0.77
[Cancer surgery for diffuse hepatic metastases. Apropos of 30 cases]. Chirurgie (1987) 0.77
Repeat hepatic resection for metachronous carcinoma of the liver. J R Coll Surg Edinb (1992) 0.77
Reresection of colorectal liver secondaries: a preliminary report. HPB Surg (1990) 0.77
Lactose carrier protein of Escherichia coli. Structure and expression of plasmids carrying the Y gene of the lac operon. Eur J Biochem (1980) 3.24
The Rapunzel syndrome. An unusual complication of intestinal bezoar. Surgery (1968) 3.21
A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy. Ann Surg (1995) 2.58
The relationship of alterations in systolic time intervals to ejection fraction in patients with cardiac disease. Circulation (1970) 2.58
Comparative studies of the clinical effects of truncal and selective gastric vagotomy. Am J Surg (1968) 2.37
Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest (1994) 2.33
In vitro and in vivo products of E. coli lactose permease gene are identical. Nature (1980) 2.18
Esophageal perforation: an increasing challenge. Ann Thorac Surg (1975) 2.07
Pancreatoduodenectomy with pyloric preservation for carcinoma of the pancreas: a cautionary note. Surgery (1989) 1.92
Management of infections from self inoculation with lighter flui and other foreign agents. Ann Surg (1969) 1.92
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant (2012) 1.88
The structure of the lactose permease derived from Raman spectroscopy and prediction methods. EMBO J (1985) 1.79
Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg (1998) 1.63
Surgical management of reflux gastritis. Ann Surg (1974) 1.60
Anomalous branch of the internal carotid artery maintains patency distal to a complete occlusion diagnosed by duplex scan. J Vasc Surg (1997) 1.59
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant (2013) 1.54
Living related kidney donors. A 14-year experience. Ann Surg (1986) 1.53
Anti-peptide antibodies and proteases as structural probes for the lactose/H+ transporter of Escherichia coli: a loop around amino acid residue 130 faces the cytoplasmic side of the membrane. Biochemistry (1986) 1.53
Peptide-specific antibody locates the COOH terminus of the lactose carrier of Escherichia coli on the cytoplasmic side of the plasma membrane. J Biol Chem (1983) 1.51
Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production. Surgery (1999) 1.50
Comparison of laparoscopic cholecystectomy with open cholecystectomy in a single center. Am J Surg (1993) 1.49
Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med (1997) 1.47
Recent experience with major hepatic resection. Ann Surg (1968) 1.44
Tumor seeding from percutaneous biliary catheters. Ann Surg (1989) 1.41
Recurrent mammary carcinoma after local excision. A segmental problem. Cancer (1995) 1.41
Hepatic venous outflow obstruction in pediatric liver transplantation: technical considerations in prevention, diagnosis, and management. Pediatr Transplant (2014) 1.40
Nashville experience with liver transplantation in Veterans Administration patients. J Surg Res (1997) 1.39
Cefoxitin versus erythromycin, neomycin, and cefazolin in colorectal operations. Importance of the duration of the surgical procedure. Ann Surg (1983) 1.38
A comparison of single photon and dual X-ray absorptiometry of the forearm in children and adults. Bone (1994) 1.38
Peripheral anastomotic aneurysms. Development following arterial reconstruction with prosthetic grafts. Arch Surg (1967) 1.37
Sidedness of native membrane vesicles of Escherichia coli and orientation of the reconstituted lactose: H+ carrier. Eur J Biochem (1984) 1.37
Perforated duodenal ulcer managed by proximal gastric vagotomy and suture plication. Ann Surg (1977) 1.37
Purification of the lactose:H+ carrier of Escherichia coli and characterization of galactoside binding and transport. Eur J Biochem (1984) 1.34
Results of an aggressive surgical approach to gastric carcinoma during a twenty-three-year period. Surgery (1985) 1.33
18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg (1999) 1.32
Molecular aspects of sugar:ion cotransport. Annu Rev Biochem (1986) 1.29
Management of adult choledochal cysts. Ann Surg (1981) 1.28
Lactose carrier protein of Escherichia coli: interaction with galactosides and protons. Biochemistry (1981) 1.28
Acute perforated duodenal ulcer. An evaluation of surgical management. Arch Surg (1975) 1.27
A study of the postoperative course after hepatic lobectomy. Ann Surg (1971) 1.24
A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Ann Surg (1976) 1.20
Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med (1999) 1.19
Systolic time intervals in cardiac disease. I. Mod Concepts Cardiovasc Dis (1971) 1.19
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg (1996) 1.19
Image-guided surgery: preliminary feasibility studies of frameless stereotactic liver surgery. Arch Surg (1999) 1.19
Magnetoenterography (MENG): noninvasive measurement of bioelectric activity in human small intestine. Dig Dis Sci (1996) 1.14
A comparison of 399 open and 568 laparoscopic gastric bypasses performed during a 4-year period. Surg Endosc (2007) 1.13
Proximal gastric vagotomy compared with vagotomy and antrectomy and selective gastric vagotomy and pyloroplasty. Ann Surg (1977) 1.12
Patterns of injury in the battered child syndrome. J Trauma (1973) 1.12
Distinct functions of monoclonal IgG antibody depend on antigen-site specificities. J Exp Med (1979) 1.12
Systolic time intervals in cardiac disease (II). Mod Concepts Cardiovasc Dis (1971) 1.12
Noninvasive diagnosis of mesenteric ischemia using a SQUID magnetometer. Ann Surg (1995) 1.12
Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery (1990) 1.11
Barrett's esophagus. A surgical entity. Arch Surg (1984) 1.10
Colorectal carcinoma in pregnancy. Arch Surg (1985) 1.09
Perforated gastric ulcers. A plea for management by primary gastric resection. Arch Surg (1987) 1.09
Results of elective duodenal ulcer surgery in women: comparison of truncal vagotomy and antrectomy, gastric selective vagotomy and pyloroplasty, proximal gastric vagotomy. Ann Surg (1978) 1.09
Bile duct injury following laparoscopic cholecystectomy: a cause for continued concern. Am Surg (2001) 1.08
Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg (1999) 1.08
Surface registration for use in interactive, image-guided liver surgery. Comput Aided Surg (2000) 1.08
The size of the lactose permease derived from rotational diffusion measurements. EMBO J (1985) 1.08
Isolation of the globular region of the subcomponent q of the C1 component of complement. Hoppe Seylers Z Physiol Chem (1979) 1.08
Does the lactose carrier of Escherichia coli function as a monomer? FEBS Lett (1983) 1.07
Evaluation of three methods for managing penetrating colon injuries. J Trauma (1975) 1.07
Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase. Matrix (1992) 1.07
Management of bronchobiliary fistula as a late complication of hepatic resection. Am Surg (1998) 1.05
Dysphagia lusoria: aberrant right subclavian artery with a Kommerell's diverticulum. Am Surg (1993) 1.04
Surgical management of esophageal perforation. Am Surg (1987) 1.03
Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement. Biochem J (1980) 1.02
Ischemic colitis. An ever-changing spectrum? Am Surg (1991) 1.01
Lactose permease of Escherichia coli: properties of mutants defective in substrate translocation. Proc Natl Acad Sci U S A (1987) 1.00
Technical advances toward interactive image-guided laparoscopic surgery. Surg Endosc (2000) 1.00
The surgical management of stress ulcers. Ann Surg (1969) 1.00
Benign bronchial polyps and papillomas. Ann Thorac Surg (1971) 0.99
Gastrointestinal tuberculosis: resurgence of an old pathogen. Am Surg (1989) 0.99
The management of gastric ulcers. A current review. Ann Surg (1985) 0.99
Current status of conventional (open) cholecystectomy versus laparoscopic cholecystectomy. Ann Surg (1996) 0.98
Vagotomy and antrectomy in surgical treatment of duodenal ulcer disease. Surg Clin North Am (1966) 0.98
Long-term results of Roux-en-Y hepatocholangiojejunostomy. Ann Surg (1973) 0.98
Experience with vagotomy--antrectomy and Roux-en-Y gastrojejunostomy in surgical treatment of duodenal, gastric, and stomal ulcers. Ann Surg (1984) 0.98
Clinical trial of vagotomy and pyloroplasty in the treatment of benign gastric ulcer. Am J Surg (1971) 0.98
Coarctation of the abdominal aorta: pathophysiologic and therapeutic considerations. Ann Surg (1979) 0.97
Radical resection improves survival for patients with pT2 gallbladder carcinoma. Am Surg (2001) 0.97
Embryology, anatomy, and surgical applications of the extrahepatic biliary system. Surg Clin North Am (2000) 0.96
Improved islet yields from pancreas preserved in perflurocarbon is via inhibition of apoptosis mediated by mitochondrial pathway. Am J Transplant (2006) 0.96
Surgical treatment of popliteal artery injuries. Arch Surg (1975) 0.96
Carcinoids and the carcinoid syndrome. Am J Surg (1983) 0.95
A 25-year experience with vagotomy-antrectomy. Arch Surg (1973) 0.95